U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07459673) titled 'A Study Using ctDNA to Guide Treatment for People With HER2-positive Breast Cancer' on March 05.
Brief Summary: Thie purpose of this study is to find out whether a personalized treatment approach-using a series of ctDNA tests along with standard imaging scans to help decide when to step up (escalate) or decrease (de-escalate) sequential treatments (given one after another)-combined with local therapies (which treat cancer in a specific part of the body) and treatments that prevent cancer from spreading to the central nervous system (CNS; including the brain and spinal cord) can result in long-lasting remission and possibly cure som...